Gesundheitswissenschaftliches Journal

  • ISSN: 1108-7366
  • H-Index der Zeitschrift: 51
  • Zitierbewertung der Zeitschrift: 10.69
  • Journal-Impact-Faktor: 9.13
Indiziert in
  • Genamics JournalSeek
  • Nationale Wissensinfrastruktur Chinas (CNKI)
  • CiteFactor
  • CINAHL Komplett
  • Scimago
  • Elektronische Zeitschriftenbibliothek
  • Verzeichnis der Indexierung von Forschungszeitschriften (DRJI)
  • EMCare
  • OCLC – WorldCat
  • Kommission für Universitätsstipendien
  • Genfer Stiftung für medizinische Ausbildung und Forschung
  • Euro-Pub
  • Google Scholar
  • SHERPA ROMEO
  • Geheime Suchmaschinenlabore
Teile diese Seite

Abstrakt

N-linked Glycosylation and its Potential Application in Drug Development

Shilei Wang, Quanyong He, Jinlei Ye, Zhichao Kang, Qiping Zheng, Shuo Liu, Jun He and Lichun Sun

Protein glycosylation is a site-specific enzymatic process to attach oligosaccharides or carbohydrates to proteins. N-linked glycosylation (N-glycosylation) is the major type of glycosylation for the post-translational and co-translational modification of proteins in eukaryotic cells. N-linked glycosylation is to link saccharide molecules to proteins via covalently coupling oligosaccharides or glycans to the amino acid residue asparagine (Asn, N) of proteins, mostly with the requirement of a Asn–X–Ser/Thr (N-X-S/T) consensus sequence. N-linked protein glycosylation is of significance and plays critical roles in biological and pathological processes, and also applied for modern drug development. Particularly, the strategy to engineer N-linked glycosylation site(s) can stabilize the recombinant fusion proteins. This technology has been widely applied for drug discovery, especially for the peptide drugs such as rabies viral glycoprotein (RVG), cardiac-targeting peptide (CTP), bovine adrenal medulla (BAM).